世界のジェネリック医薬品有効成分市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV06747)
◆英語タイトル:Global Generic Active Pharmaceutical Ingredients Market Insights and Forecast to 2026
◆商品コード:QYR20NV06747
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはジェネリック医薬品有効成分の世界市場について調査・分析した資料です。種類別(モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子)の市場規模、用途別(腫瘍学、糖尿病、心血管疾患、CNS・神経障害、内分泌学、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ジェネリック医薬品有効成分の競争状況、市場シェア
・世界のジェネリック医薬品有効成分市場:種類別市場規模 2015年-2020年(モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子)
・世界のジェネリック医薬品有効成分市場:種類別市場規模予測 2021年-2026年(モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子)
・世界のジェネリック医薬品有効成分市場:用途別市場規模 2015年-2020年(腫瘍学、糖尿病、心血管疾患、CNS・神経障害、内分泌学、その他)
・世界のジェネリック医薬品有効成分市場:用途別市場規模予測 2021年-2026年(腫瘍学、糖尿病、心血管疾患、CNS・神経障害、内分泌学、その他)
・北米のジェネリック医薬品有効成分市場分析:米国、カナダ
・ヨーロッパのジェネリック医薬品有効成分市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのジェネリック医薬品有効成分市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のジェネリック医薬品有効成分市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのジェネリック医薬品有効成分市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer, Inc. (U.S.)、Novartis International AG (Switzerland)、Sanofi (France)、Boehringer Ingelheim (Germany)、Bristol-Myers Squibb (U.S.)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (U.S.)、GlaxoSmithKline plc (U.K.)、Merck & Co., Inc. (U.S.)、AbbVie Inc. (U.S.)
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Generic Active Pharmaceutical Ingredients Market
The global Generic Active Pharmaceutical Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Generic Active Pharmaceutical Ingredients Scope and Market Size
Generic Active Pharmaceutical Ingredients market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Generic Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Generic Active Pharmaceutical Ingredients market is segmented into
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors

Segment by Application, the Generic Active Pharmaceutical Ingredients market is segmented into
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others

Regional and Country-level Analysis
The Generic Active Pharmaceutical Ingredients market is analysed and market size information is provided by regions (countries).
The key regions covered in the Generic Active Pharmaceutical Ingredients market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Generic Active Pharmaceutical Ingredients Market Share Analysis
Generic Active Pharmaceutical Ingredients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Generic Active Pharmaceutical Ingredients business, the date to enter into the Generic Active Pharmaceutical Ingredients market, Generic Active Pharmaceutical Ingredients product introduction, recent developments, etc.

The major vendors covered:
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)

【レポートの目次】

1 Study Coverage
1.1 Generic Active Pharmaceutical Ingredients Product Introduction
1.2 Market Segments
1.3 Key Generic Active Pharmaceutical Ingredients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Hormones
1.4.4 Cytokines
1.4.5 Fusion Proteins
1.4.6 Therapeutic Enzymes
1.4.7 Vaccines
1.4.8 Blood Factors
1.5 Market by Application
1.5.1 Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Disease
1.5.5 CNS and Neurological Disorders
1.5.6 Endocrinology
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Generic Active Pharmaceutical Ingredients Market Size, Estimates and Forecasts
2.1.1 Global Generic Active Pharmaceutical Ingredients Revenue 2015-2026
2.1.2 Global Generic Active Pharmaceutical Ingredients Sales 2015-2026
2.2 Global Generic Active Pharmaceutical Ingredients, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Generic Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Generic Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Generic Active Pharmaceutical Ingredients Competitor Landscape by Players
3.1 Generic Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.1 Generic Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020)
3.1.2 Generic Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)
3.2 Generic Active Pharmaceutical Ingredients Revenue by Manufacturers
3.2.1 Generic Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020)
3.2.2 Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Generic Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Generic Active Pharmaceutical Ingredients Revenue in 2019
3.2.5 Global Generic Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Generic Active Pharmaceutical Ingredients Price by Manufacturers
3.4 Generic Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
3.4.1 Generic Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Generic Active Pharmaceutical Ingredients Product Type
3.4.3 Date of International Manufacturers Enter into Generic Active Pharmaceutical Ingredients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Generic Active Pharmaceutical Ingredients Market Size by Type (2015-2020)
4.1.1 Global Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020)
4.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Type (2015-2020)
4.1.3 Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Generic Active Pharmaceutical Ingredients Market Size Forecast by Type (2021-2026)
4.2.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026)
4.2.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026)
4.2.3 Generic Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Generic Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Generic Active Pharmaceutical Ingredients Market Size by Application (2015-2020)
5.1.1 Global Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020)
5.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Application (2015-2020)
5.1.3 Generic Active Pharmaceutical Ingredients Price by Application (2015-2020)
5.2 Generic Active Pharmaceutical Ingredients Market Size Forecast by Application (2021-2026)
5.2.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026)
5.2.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026)
5.2.3 Global Generic Active Pharmaceutical Ingredients Price Forecast by Application (2021-2026)

6 North America
6.1 North America Generic Active Pharmaceutical Ingredients by Country
6.1.1 North America Generic Active Pharmaceutical Ingredients Sales by Country
6.1.2 North America Generic Active Pharmaceutical Ingredients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
6.3 North America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

7 Europe
7.1 Europe Generic Active Pharmaceutical Ingredients by Country
7.1.1 Europe Generic Active Pharmaceutical Ingredients Sales by Country
7.1.2 Europe Generic Active Pharmaceutical Ingredients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
7.3 Europe Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Generic Active Pharmaceutical Ingredients by Region
8.1.1 Asia Pacific Generic Active Pharmaceutical Ingredients Sales by Region
8.1.2 Asia Pacific Generic Active Pharmaceutical Ingredients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
8.3 Asia Pacific Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

9 Latin America
9.1 Latin America Generic Active Pharmaceutical Ingredients by Country
9.1.1 Latin America Generic Active Pharmaceutical Ingredients Sales by Country
9.1.2 Latin America Generic Active Pharmaceutical Ingredients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
9.3 Central & South America Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Generic Active Pharmaceutical Ingredients by Country
10.1.1 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country
10.1.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Market Facts & Figures by Type
10.3 Middle East and Africa Generic Active Pharmaceutical Ingredients Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer, Inc. (U.S.)
11.1.1 Pfizer, Inc. (U.S.) Corporation Information
11.1.2 Pfizer, Inc. (U.S.) Description and Business Overview
11.1.3 Pfizer, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.1.5 Pfizer, Inc. (U.S.) Related Developments
11.2 Novartis International AG (Switzerland)
11.2.1 Novartis International AG (Switzerland) Corporation Information
11.2.2 Novartis International AG (Switzerland) Description and Business Overview
11.2.3 Novartis International AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Products Offered
11.2.5 Novartis International AG (Switzerland) Related Developments
11.3 Sanofi (France)
11.3.1 Sanofi (France) Corporation Information
11.3.2 Sanofi (France) Description and Business Overview
11.3.3 Sanofi (France) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi (France) Generic Active Pharmaceutical Ingredients Products Offered
11.3.5 Sanofi (France) Related Developments
11.4 Boehringer Ingelheim (Germany)
11.4.1 Boehringer Ingelheim (Germany) Corporation Information
11.4.2 Boehringer Ingelheim (Germany) Description and Business Overview
11.4.3 Boehringer Ingelheim (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Products Offered
11.4.5 Boehringer Ingelheim (Germany) Related Developments
11.5 Bristol-Myers Squibb (U.S.)
11.5.1 Bristol-Myers Squibb (U.S.) Corporation Information
11.5.2 Bristol-Myers Squibb (U.S.) Description and Business Overview
11.5.3 Bristol-Myers Squibb (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.5.5 Bristol-Myers Squibb (U.S.) Related Developments
11.6 Teva Pharmaceutical Industries Ltd. (Israel)
11.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Products Offered
11.6.5 Teva Pharmaceutical Industries Ltd. (Israel) Related Developments
11.7 Eli Lilly and Company (U.S.)
11.7.1 Eli Lilly and Company (U.S.) Corporation Information
11.7.2 Eli Lilly and Company (U.S.) Description and Business Overview
11.7.3 Eli Lilly and Company (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.7.5 Eli Lilly and Company (U.S.) Related Developments
11.8 GlaxoSmithKline plc (U.K.)
11.8.1 GlaxoSmithKline plc (U.K.) Corporation Information
11.8.2 GlaxoSmithKline plc (U.K.) Description and Business Overview
11.8.3 GlaxoSmithKline plc (U.K.) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Products Offered
11.8.5 GlaxoSmithKline plc (U.K.) Related Developments
11.9 Merck & Co., Inc. (U.S.)
11.9.1 Merck & Co., Inc. (U.S.) Corporation Information
11.9.2 Merck & Co., Inc. (U.S.) Description and Business Overview
11.9.3 Merck & Co., Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.9.5 Merck & Co., Inc. (U.S.) Related Developments
11.10 AbbVie Inc. (U.S.)
11.10.1 AbbVie Inc. (U.S.) Corporation Information
11.10.2 AbbVie Inc. (U.S.) Description and Business Overview
11.10.3 AbbVie Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.10.5 AbbVie Inc. (U.S.) Related Developments
11.1 Pfizer, Inc. (U.S.)
11.1.1 Pfizer, Inc. (U.S.) Corporation Information
11.1.2 Pfizer, Inc. (U.S.) Description and Business Overview
11.1.3 Pfizer, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
11.1.5 Pfizer, Inc. (U.S.) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Generic Active Pharmaceutical Ingredients Market Estimates and Projections by Region
12.1.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Regions 2021-2026
12.1.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Regions 2021-2026
12.2 North America Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.2.1 North America: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.2.2 North America: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.2.3 North America: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.3 Europe Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.3.1 Europe: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.3.2 Europe: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.3.3 Europe: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Generic Active Pharmaceutical Ingredients Market Size Forecast by Region (2021-2026)
12.5 Latin America Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.5.1 Latin America: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.5.2 Latin America: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.5.3 Latin America: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Generic Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Generic Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Generic Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Generic Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Generic Active Pharmaceutical Ingredients Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Generic Active Pharmaceutical Ingredients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Pfizer, Inc. (U.S.)、Novartis International AG (Switzerland)、Sanofi (France)、Boehringer Ingelheim (Germany)、Bristol-Myers Squibb (U.S.)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (U.S.)、GlaxoSmithKline plc (U.K.)、Merck & Co., Inc. (U.S.)、AbbVie Inc. (U.S.)

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のジェネリック医薬品有効成分市場2026:インサイト・予測(Global Generic Active Pharmaceutical Ingredients Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。